BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29199361)

  • 21. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.
    Nikou GC; Pazaitou-Panayiotou K; Dimitroulopoulos D; Alexandrakis G; Papakostas P; Vaslamatzis M; Kaldrymidis P; Markussis V; Koumarianou A;
    BMC Endocr Disord; 2016 Feb; 16():8. PubMed ID: 26872616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
    Santhanam P; Chandramahanti S; Kroiss A; Yu R; Ruszniewski P; Kumar R; Taïeb D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1144-55. PubMed ID: 25771906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
    Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
    J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capsule endoscopy to detect primary tumour site in metastatic neuroendocrine tumours.
    Frilling A; Smith G; Clift AK; Martin J
    Dig Liver Dis; 2014 Nov; 46(11):1038-42. PubMed ID: 25086997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine tumor disease: an evolving landscape.
    Frilling A; Akerström G; Falconi M; Pavel M; Ramos J; Kidd M; Modlin IM
    Endocr Relat Cancer; 2012 Oct; 19(5):R163-85. PubMed ID: 22645227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (68)Ga-DOTATATE PET/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin.
    Alonso O; Rodríguez-Taroco M; Savio E; Bentancourt C; Gambini JP; Engler H
    Ann Nucl Med; 2014 Aug; 28(7):638-45. PubMed ID: 24862238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of neuroendocrine tumors of unknown origin.
    Polish A; Vergo MT; Agulnik M
    J Natl Compr Canc Netw; 2011 Dec; 9(12):1397-402; quiz 1403. PubMed ID: 22157557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress in diagnosis and treatment of rectal neuroendocrine neoplasms].
    Wu ZJ; Zhou MY; Zheng ZX; Bi JJ; Wang XS; Feng Q
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):438-444. PubMed ID: 32575937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
    Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
    Bednarczuk T; Bolanowski M; Zemczak A; Bałdys-Waligórska A; Blicharz-Dorniak J; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nowakowska-Duława E; Pałucki J; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Strzelczyk J; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zgliczyński W; Kos-Kudła B
    Endokrynol Pol; 2017; 68(2):223-236. PubMed ID: 28540974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery for metastatic neuroendocrine tumors with occult primaries.
    Bartlett EK; Roses RE; Gupta M; Shah PK; Shah KK; Zaheer S; Wachtel H; Kelz RR; Karakousis GC; Fraker DL
    J Surg Res; 2013 Sep; 184(1):221-7. PubMed ID: 23643298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopy and Endoscopic Ultrasound in Assessing and Managing Neuroendocrine Neoplasms.
    O'Toole D; Palazzo L
    Front Horm Res; 2015; 44():88-103. PubMed ID: 26303706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine neoplasms of the small intestine and the appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
    Bolanowski M; Bednarczuk T; Bobek-Billewicz B; Handkiewicz-Junak D; Jeziorski A; Nowakowska-Duława E; Steinhof-Radwańska K; Zajęcki W; Zemczak A; Kos-Kudła B; ;
    Endokrynol Pol; 2013; 64(6):480-93. PubMed ID: 24431119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
    Fottner C; Ferrata M; Weber MM
    Rev Endocr Metab Disord; 2017 Dec; 18(4):393-410. PubMed ID: 29256148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine Tumour Of Unknown Primary Origin: Unusual Case Of Metastatic Hepatic Foci In A Female Patient.
    Khan AA; Bin Waqar SH; Mohiuddin O; Ehtesham M; Jalees S
    J Ayub Med Coll Abbottabad; 2020; 32(1):127-131. PubMed ID: 32468771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors.
    Furnari M; Buda A; Delconte G; Citterio D; Voiosu T; Ballardini G; Cavallaro F; Savarino E; Mazzaferro V; Meroni E
    J Gastrointestin Liver Dis; 2017 Jun; 26(2):151-156. PubMed ID: 28617885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin.
    Naswa N; Sharma P; Kumar A; Soundararajan R; Kumar R; Malhotra A; Ammini AC; Bal C
    Clin Nucl Med; 2012 Mar; 37(3):245-51. PubMed ID: 22310250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA
    Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.